1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Haemostatic Sponge Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Medical Haemostatic Sponge by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Medical Haemostatic Sponge by Country/Region, 2018, 2022 & 2029
2.2 Medical Haemostatic Sponge Segment by Type
2.2.1 Gelatin Sponge
2.2.2 Chitosan Sponge
2.2.3 Collagen Sponge
2.2.4 Others
2.3 Medical Haemostatic Sponge Sales by Type
2.3.1 Global Medical Haemostatic Sponge Sales Market Share by Type (2018-2023)
2.3.2 Global Medical Haemostatic Sponge Revenue and Market Share by Type (2018-2023)
2.3.3 Global Medical Haemostatic Sponge Sale Price by Type (2018-2023)
2.4 Medical Haemostatic Sponge Segment by Application
2.4.1 Surgical Wound Care
2.4.2 General Wound Care
2.5 Medical Haemostatic Sponge Sales by Application
2.5.1 Global Medical Haemostatic Sponge Sale Market Share by Application (2018-2023)
2.5.2 Global Medical Haemostatic Sponge Revenue and Market Share by Application (2018-2023)
2.5.3 Global Medical Haemostatic Sponge Sale Price by Application (2018-2023)
3 Global Medical Haemostatic Sponge by Company
3.1 Global Medical Haemostatic Sponge Breakdown Data by Company
3.1.1 Global Medical Haemostatic Sponge Annual Sales by Company (2018-2023)
3.1.2 Global Medical Haemostatic Sponge Sales Market Share by Company (2018-2023)
3.2 Global Medical Haemostatic Sponge Annual Revenue by Company (2018-2023)
3.2.1 Global Medical Haemostatic Sponge Revenue by Company (2018-2023)
3.2.2 Global Medical Haemostatic Sponge Revenue Market Share by Company (2018-2023)
3.3 Global Medical Haemostatic Sponge Sale Price by Company
3.4 Key Manufacturers Medical Haemostatic Sponge Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Haemostatic Sponge Product Location Distribution
3.4.2 Players Medical Haemostatic Sponge Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical Haemostatic Sponge by Geographic Region
4.1 World Historic Medical Haemostatic Sponge Market Size by Geographic Region (2018-2023)
4.1.1 Global Medical Haemostatic Sponge Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Medical Haemostatic Sponge Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Medical Haemostatic Sponge Market Size by Country/Region (2018-2023)
4.2.1 Global Medical Haemostatic Sponge Annual Sales by Country/Region (2018-2023)
4.2.2 Global Medical Haemostatic Sponge Annual Revenue by Country/Region (2018-2023)
4.3 Americas Medical Haemostatic Sponge Sales Growth
4.4 APAC Medical Haemostatic Sponge Sales Growth
4.5 Europe Medical Haemostatic Sponge Sales Growth
4.6 Middle East & Africa Medical Haemostatic Sponge Sales Growth
5 Americas
5.1 Americas Medical Haemostatic Sponge Sales by Country
5.1.1 Americas Medical Haemostatic Sponge Sales by Country (2018-2023)
5.1.2 Americas Medical Haemostatic Sponge Revenue by Country (2018-2023)
5.2 Americas Medical Haemostatic Sponge Sales by Type
5.3 Americas Medical Haemostatic Sponge Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Haemostatic Sponge Sales by Region
6.1.1 APAC Medical Haemostatic Sponge Sales by Region (2018-2023)
6.1.2 APAC Medical Haemostatic Sponge Revenue by Region (2018-2023)
6.2 APAC Medical Haemostatic Sponge Sales by Type
6.3 APAC Medical Haemostatic Sponge Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Haemostatic Sponge by Country
7.1.1 Europe Medical Haemostatic Sponge Sales by Country (2018-2023)
7.1.2 Europe Medical Haemostatic Sponge Revenue by Country (2018-2023)
7.2 Europe Medical Haemostatic Sponge Sales by Type
7.3 Europe Medical Haemostatic Sponge Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Haemostatic Sponge by Country
8.1.1 Middle East & Africa Medical Haemostatic Sponge Sales by Country (2018-2023)
8.1.2 Middle East & Africa Medical Haemostatic Sponge Revenue by Country (2018-2023)
8.2 Middle East & Africa Medical Haemostatic Sponge Sales by Type
8.3 Middle East & Africa Medical Haemostatic Sponge Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Haemostatic Sponge
10.3 Manufacturing Process Analysis of Medical Haemostatic Sponge
10.4 Industry Chain Structure of Medical Haemostatic Sponge
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Haemostatic Sponge Distributors
11.3 Medical Haemostatic Sponge Customer
12 World Forecast Review for Medical Haemostatic Sponge by Geographic Region
12.1 Global Medical Haemostatic Sponge Market Size Forecast by Region
12.1.1 Global Medical Haemostatic Sponge Forecast by Region (2024-2029)
12.1.2 Global Medical Haemostatic Sponge Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Haemostatic Sponge Forecast by Type
12.7 Global Medical Haemostatic Sponge Forecast by Application
13 Key Players Analysis
13.1 Bard
13.1.1 Bard Company Information
13.1.2 Bard Medical Haemostatic Sponge Product Portfolios and Specifications
13.1.3 Bard Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bard Main Business Overview
13.1.5 Bard Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Medical Haemostatic Sponge Product Portfolios and Specifications
13.2.3 Pfizer Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Medical Haemostatic Sponge Product Portfolios and Specifications
13.3.3 Johnson & Johnson Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Baxter
13.4.1 Baxter Company Information
13.4.2 Baxter Medical Haemostatic Sponge Product Portfolios and Specifications
13.4.3 Baxter Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Baxter Main Business Overview
13.4.5 Baxter Latest Developments
13.5 Ferrosan Medical Devices
13.5.1 Ferrosan Medical Devices Company Information
13.5.2 Ferrosan Medical Devices Medical Haemostatic Sponge Product Portfolios and Specifications
13.5.3 Ferrosan Medical Devices Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ferrosan Medical Devices Main Business Overview
13.5.5 Ferrosan Medical Devices Latest Developments
13.6 Gelita Medical
13.6.1 Gelita Medical Company Information
13.6.2 Gelita Medical Medical Haemostatic Sponge Product Portfolios and Specifications
13.6.3 Gelita Medical Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Gelita Medical Main Business Overview
13.6.5 Gelita Medical Latest Developments
13.7 Equimedical
13.7.1 Equimedical Company Information
13.7.2 Equimedical Medical Haemostatic Sponge Product Portfolios and Specifications
13.7.3 Equimedical Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Equimedical Main Business Overview
13.7.5 Equimedical Latest Developments
13.8 Biocer
13.8.1 Biocer Company Information
13.8.2 Biocer Medical Haemostatic Sponge Product Portfolios and Specifications
13.8.3 Biocer Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biocer Main Business Overview
13.8.5 Biocer Latest Developments
13.9 Celox
13.9.1 Celox Company Information
13.9.2 Celox Medical Haemostatic Sponge Product Portfolios and Specifications
13.9.3 Celox Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Celox Main Business Overview
13.9.5 Celox Latest Developments
13.10 Hemostasis
13.10.1 Hemostasis Company Information
13.10.2 Hemostasis Medical Haemostatic Sponge Product Portfolios and Specifications
13.10.3 Hemostasis Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hemostasis Main Business Overview
13.10.5 Hemostasis Latest Developments
13.11 MBP
13.11.1 MBP Company Information
13.11.2 MBP Medical Haemostatic Sponge Product Portfolios and Specifications
13.11.3 MBP Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 MBP Main Business Overview
13.11.5 MBP Latest Developments
13.12 Medira
13.12.1 Medira Company Information
13.12.2 Medira Medical Haemostatic Sponge Product Portfolios and Specifications
13.12.3 Medira Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Medira Main Business Overview
13.12.5 Medira Latest Developments
13.13 Hemotec Medical
13.13.1 Hemotec Medical Company Information
13.13.2 Hemotec Medical Medical Haemostatic Sponge Product Portfolios and Specifications
13.13.3 Hemotec Medical Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hemotec Medical Main Business Overview
13.13.5 Hemotec Medical Latest Developments
13.14 Starch Medical
13.14.1 Starch Medical Company Information
13.14.2 Starch Medical Medical Haemostatic Sponge Product Portfolios and Specifications
13.14.3 Starch Medical Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Starch Medical Main Business Overview
13.14.5 Starch Medical Latest Developments
13.15 Success Pharmaceutical
13.15.1 Success Pharmaceutical Company Information
13.15.2 Success Pharmaceutical Medical Haemostatic Sponge Product Portfolios and Specifications
13.15.3 Success Pharmaceutical Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Success Pharmaceutical Main Business Overview
13.15.5 Success Pharmaceutical Latest Developments
13.16 Changsha Hairun
13.16.1 Changsha Hairun Company Information
13.16.2 Changsha Hairun Medical Haemostatic Sponge Product Portfolios and Specifications
13.16.3 Changsha Hairun Medical Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Changsha Hairun Main Business Overview
13.16.5 Changsha Hairun Latest Developments
14 Research Findings and Conclusion
| ※参考情報 医療用止血スポンジは外科手術や外傷治療において出血を抑えるために使用される医療機器の一つです。止血スポンジは、出血した部位に置かれることで、血液の凝固を促進し、出血の制御に寄与します。この技術は急性の出血状態に対処するための重要な手段であり、特に外科手術や外傷治療の現場で広く利用されています。 医療用止血スポンジの主な特徴の一つは、その高い親水性にあります。多くの止血スポンジは、特別に設計された多孔質構造を持っており、これによって血液を吸収し、湿潤環境を整えることができます。この環境は血小板が集まりやすくなり、結果的に血液の凝固を促進する役割を果たします。また、止血スポンジは柔軟性があり、さまざまな形状の傷口に適応できるため、取り扱いが容易です。 止血スポンジの種類には、主に天然素材を使用したものと合成素材を使用したものがあります。天然素材には、コラーゲンやゼラチン、デキストランなどが含まれています。これらの素材は生体適合性が高く、体内に自然に吸収されることが特長です。一方、合成素材を用いたスポンジも存在し、これにはポリマーや合成繊維が利用されています。これらは安定性や強度、コスト面でのメリットがありますが、生体反応については天然素材に比べて慎重な評価が必要です。 止血スポンジの用途は非常に広範で、手術中の出血制御や、外傷後の止血、血液透析やカテーテル挿入時の出血予防など多岐にわたります。また、特に外科手術では、内臓手術や整形外科手術など、出血のリスクが高い手術の際に重要な役割を果たします。一方で、外傷治療においては、緊急対応としての使用が求められる場合が多く、迅速な止血が患者の予後に大きく影響することがあります。 さらに、関連技術も進化し続けています。例えば、最近では、止血スポンジに特別な薬剤を添加することで止血効果を高める試みが行われています。これにより、より効果的に出血を抑えつつ、傷の治癒を助けることが期待されています。また、止血スポンジを用いた手術技術に関する研究や、より高性能な素材の開発も進行中です。これにより、患者のQOL（生活の質）の向上や、医療現場の効率化が期待されます。 医療用止血スポンジは、現代医療において不可欠なアイテムとなっており、その技術と応用は今後も進化し続けることでしょう。出血が制御されることで、合併症のリスクを低減し、患者の回復を早めることができるため、その重要性はますます高まっています。医療従事者にとっては、止血スポンジを正しく選び、使用することが、患者の安全と回復につながる鍵となります。 |
